Last Word


Copyright: This PDF purchase is for a Single user for review or filing purposes only. The PDF is watermarked. If you are interested in a PDF reprint to post on your website or distribute electronically, or hard-copy reprints, please contact Marah Walsh at

SKU: 1693.

Product Description

For Clayton Christensen, disruption can be both a threat and an opportunity — it all depends how a company frames it. In general, though, Mr. Christensen views disruptive innovation as a huge growth opportunity for the pharmaceutical industry.

Mr. Christensen believes the changing dynamics of the healthcare industry mean companies need to rethink their models and focus on their core critical competencies — discovery, development, and clinical research.